Osteoporosis Treatment Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
In recent years, the market size for osteoporosis treatment has shown a consistent increase. There's an anticipated growth from $13.96 billion in 2024 to $14.62 billion in 2025 with a compound annual growth rate (CAGR) of 4.8%. Factors that contributed to this growth in the past include the demographic of an ageing population, the use of hormone replacement therapies, supplementation of calcium and vitamin D, enhanced diagnostic tools, and the adoption of digital health solutions.

In the coming years, the market size for osteoporosis treatment is projected to experience robust growth, expanding to $17.84 billion by 2029 with a compound annual growth rate (CAGR) of 5.1%. The expected growth over the forecast period is related to increasing sedentary lifestyles, a higher incidence of secondary osteoporosis, the emergence of virtual bone fracture clinics, gene therapy breakthroughs in the field of osteoporosis, and a greater emphasis on men's bone health. Major trends for the forecast period involve progress in biologics, the incorporation of artificial intelligence and blockchain in bone health records, and the integration of machine learning.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166

How Are Emerging Segments Shaping the Osteoporosis Treatment Market Landscape?
The osteoporosis treatment market covered in this report is segmented -

1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor
2) By Route Of Administration: Oral, Injectable, Other Routes
3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:
1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations
3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)
4) By Selective Estrogen Receptor Modulators (SERMs), Raloxifene, Bazedoxifene
5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide), Other PTHrP Analogues
6) By Rank Ligand (RANKL) Inhibito: Denosumab

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

Which Growth Factors Are Influencing Osteoporosis Treatment Market Expansion?
The osteoporosis treatment market's growth is projected to surge due to the rising occurrences of osteoporosis. This bone disease becomes apparent when there are alterations in bone strength and components or when bone mass and mineral density deplete. The majority of medications for osteoporosis work by decreasing your bones' rate of degeneration. Concurrently, treatments based on hormones such as estrogen can contribute to maintaining bone density, particularly if they are administered right after menopause. For example, Amgen, a biopharmaceutical corporation based in the U.S., stated in May 2022 that the annual count of fractures caused by osteoporosis is projected to grow by 68% to 3.2 million by 2040. Moreover, in April 2022, the National Library of Medicine, a health professionals' national resource in the US, reported that approximately 549,000 new fragility fractures occur annually in the UK, with men accounting for a third of these cases. This figure is anticipated to increase by 19.6% by 2030 due to an aging population. As a result, the escalating prevalence and incidence of osteoporosis are spurring the expansion of the osteoporosis treatment market.

Who Are the Dominant Players Across Different Osteoporosis Treatment Market Segments?
Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy's Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA

What Are the Latest Developing Trends in the Osteoporosis Treatment Market?
In a bid to maintain their dominance in the market, major firms in the osteoporosis treatment sector are investing in the development of cutting-edge injectable therapies for osteoporosis. Such treatments, administered by injections, help prevent bone loss and reduce the chances of fractures among osteoporosis patients. They offer a direct means to enhance bone density and boost the health of the skeletal system. For instance, in November 2023, Teriparatide Injection was launched by Apotex Corp., a renowned pharmaceutical company based in Canada. This is a pre-filled pen designed for single-patient use specifically for treating osteoporosis. With a concentration of 250 mcg/mL, it provides 28 daily doses of 20 mcg each per pen. The launch of this product aims to increase the availability of cost-effective treatment for roughly 10 million Americans battling osteoporosis. This move underlines Apotex's commitment to manufacturing complex generic drugs, thereby ensuring that patients are treated with high-quality medication.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

Which Geographic Regions Are Expected to Dominate the Osteoporosis Treatment Market in the Coming Years?
North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Osteoporosis Treatment Market?
2. What is the CAGR expected in the Osteoporosis Treatment Market?
3. What Are the Key Innovations Transforming the Osteoporosis Treatment Industry?
4. Which Region Is Leading the Osteoporosis Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.